Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04484623 |
Title | Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma (DREAMM 8) |
Acronym | DREAMM 8 |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | TUR | POL | NZL | ITA | ISR | GRC | GBR | FRA | ESP | DEU | CZE | BRA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Tucson | Arizona | 85712 | United States | Details | |
GSK Investigational Site | Fort Myers | Florida | 33901 | United States | Details | |
GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
GSK Investigational Site | Kansas City | Missouri | 64132 | United States | Details | |
GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
GSK Investigational Site | Garran | Australian Capital Territory | 2605 | Australia | Details | |
GSK Investigational Site | Darlinghurst | New South Wales | 2010 | Australia | Details | |
GSK Investigational Site | Gosford NSW | New South Wales | 2250 | Australia | Details | |
GSK Investigational Site | Port Macquarie | New South Wales | 2444 | Australia | Details | |
GSK Investigational Site | Benowa | Queensland | 4217 | Australia | Details | |
GSK Investigational Site | South Brisbane | Queensland | 4101 | Australia | Details | |
GSK Investigational Site | Adelaide | South Australia | 5000 | Australia | Details | |
GSK Investigational Site | Fitzroy | Victoria | 3065 | Australia | Details | |
GSK Investigational Site | Heidelberg | Victoria | 3084 | Australia | Details | |
GSK Investigational Site | Malvern | Victoria | 3144 | Australia | Details | |
GSK Investigational Site | Nedlands | Western Australia | 6009 | Australia | Details | |
GSK Investigational Site | Curitiba | 01308-050 | Brazil | Details | ||
GSK Investigational Site | Joinville | 89201-260 | Brazil | Details | ||
GSK Investigational Site | Porto Alegre | 90035-903 | Brazil | Details | ||
GSK Investigational Site | SAo Paulo | 04537-081 | Brazil | Details | ||
GSK Investigational Site | Beijing | 100191 | China | Details | ||
GSK Investigational Site | Beijing | China | Details | |||
GSK Investigational Site | Changchun | 130012 | China | Details | ||
GSK Investigational Site | Changsha | 410013 | China | Details | ||
GSK Investigational Site | Hangzhou | 310003 | China | Details | ||
GSK Investigational Site | Jiangsu | 221004 | China | Details | ||
GSK Investigational Site | Nanchang | 330006 | China | Details | ||
GSK Investigational Site | Shenyang | 110004 | China | Details | ||
GSK Investigational Site | Tianjin | 300020 | China | Details | ||
GSK Investigational Site | Brno | 62500 | Czechia | Details | ||
GSK Investigational Site | Hradec Kralove | 50333 | Czechia | Details | ||
GSK Investigational Site | Praha 2 | 12808 | Czechia | Details | ||
GSK Investigational Site | Marseille | 13273 | France | Details | ||
GSK Investigational Site | Toulouse cedex 9 | 31059 | France | Details | ||
GSK Investigational Site | Vanduvre-lEs-Nancy | 54511 | France | Details | ||
GSK Investigational Site | Mainz | 55131 | Germany | Details | ||
GSK Investigational Site | Tuebingen | 72076 | Germany | Details | ||
GSK Investigational Site | Wuerzburg | 97080 | Germany | Details | ||
GSK Investigational Site | Athens | 10676 | Greece | Details | ||
GSK Investigational Site | Athens | 115 25 | Greece | Details | ||
GSK Investigational Site | Athens | 115 28 | Greece | Details | ||
GSK Investigational Site | Ioannina | 45 500 | Greece | Details | ||
GSK Investigational Site | Thessaloniki | 57010 | Greece | Details | ||
GSK Investigational Site | Haifa | 3109601 | Israel | Details | ||
GSK Investigational Site | Jerusalem | 91031 | Israel | Details | ||
GSK Investigational Site | Kfar Saba | 4428164 | Israel | Details | ||
GSK Investigational Site | Nahariya | 2633737 | Israel | Details | ||
GSK Investigational Site | Petach-Tikva | 4941492 | Israel | Details | ||
GSK Investigational Site | Tel Aviv | 6423906 | Israel | Details | ||
GSK Investigational Site | Bologna | 40138 | Italy | Details | ||
GSK Investigational Site | Milano | 20122 | Italy | Details | ||
GSK Investigational Site | Pavia | 27100 | Italy | Details | ||
GSK Investigational Site | Roma | 00161 | Italy | Details | ||
GSK Investigational Site | Aichi | 467-8602 | Japan | Details | ||
GSK Investigational Site | Chiba | 277-8567 | Japan | Details | ||
GSK Investigational Site | Chiba | 296-8602 | Japan | Details | ||
GSK Investigational Site | Ehime | 790-8524 | Japan | Details | ||
GSK Investigational Site | Fukushima | 960-1295 | Japan | Details | ||
GSK Investigational Site | Gunma | 371-8511 | Japan | Details | ||
GSK Investigational Site | Gunma | 377-0280 | Japan | Details | ||
GSK Investigational Site | Hokkaido | 060-8648 | Japan | Details | ||
GSK Investigational Site | Iwate | 028-3695 | Japan | Details | ||
GSK Investigational Site | Okayama | 701-1192 | Japan | Details | ||
GSK Investigational Site | Osaka | 565-0871 | Japan | Details | ||
GSK Investigational Site | Tottori | 683-8504 | Japan | Details | ||
GSK Investigational Site | Yamagata | 990-9585 | Japan | Details | ||
GSK Investigational Site | Gyeonggi-do | 10408 | Korea, Republic of | Details | ||
GSK Investigational Site | Hwasun | 58128 | Korea, Republic of | Details | ||
GSK Investigational Site | Inchon | 21565 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 03080 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 03722 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 06351 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 06591 | Korea, Republic of | Details | ||
GSK Investigational Site | Auckland | 2025 | New Zealand | Details | ||
GSK Investigational Site | Dunedin | 9016 | New Zealand | Details | ||
GSK Investigational Site | Grafton | 1023 | New Zealand | Details | ||
GSK Investigational Site | Hamilton | 3204 | New Zealand | Details | ||
GSK Investigational Site | Takapuna Auckland | 622 | New Zealand | Details | ||
GSK Investigational Site | Tauranga | 3143 | New Zealand | Details | ||
GSK Investigational Site | Bydgoszcz | 85-168 | Poland | Details | ||
GSK Investigational Site | Gdansk | 80-214 | Poland | Details | ||
GSK Investigational Site | Krakow | 31-501 | Poland | Details | ||
GSK Investigational Site | Lodz | 93-513 | Poland | Details | ||
GSK Investigational Site | Wroclaw | 50-367 | Poland | Details | ||
GSK Investigational Site | Moscow | 125101 | Russian Federation | Details | ||
GSK Investigational Site | Moscow | 125284 | Russian Federation | Details | ||
GSK Investigational Site | Novosibirsk | 630087 | Russian Federation | Details | ||
GSK Investigational Site | Saint Petersburg | 197341 | Russian Federation | Details | ||
GSK Investigational Site | Samara | 443099 | Russian Federation | Details | ||
GSK Investigational Site | Sochi | 354057 | Russian Federation | Details | ||
GSK Investigational Site | St Petersburg | 191024 | Russian Federation | Details | ||
GSK Investigational Site | St-Petersburg | 194291 | Russian Federation | Details | ||
GSK Investigational Site | Barcelona | 08036 | Spain | Details | ||
GSK Investigational Site | Barcelona | 8035 | Spain | Details | ||
GSK Investigational Site | Gijon | 33204 | Spain | Details | ||
GSK Investigational Site | L'Hospitalet De Llobrega | 08908 | Spain | Details | ||
GSK Investigational Site | Madrid | 28006 | Spain | Details | ||
GSK Investigational Site | Madrid | 28027 | Spain | Details | ||
GSK Investigational Site | MOstoles Madrid | 28933 | Spain | Details | ||
GSK Investigational Site | Murcia | 30008 | Spain | Details | ||
GSK Investigational Site | Palma de Mallorca | 07120 | Spain | Details | ||
GSK Investigational Site | PamplonaNavarra | 31008 | Spain | Details | ||
GSK Investigational Site | Pozuelo De AlarcOn Madr | 28223 | Spain | Details | ||
GSK Investigational Site | Salamanca | 37007 | Spain | Details | ||
GSK Investigational Site | Sevilla | 41013 | Spain | Details | ||
GSK Investigational Site | Valencia | 46026 | Spain | Details | ||
GSK Investigational Site | Ankara | 06100 | Turkey | Details | ||
GSK Investigational Site | Ankara | 6340 | Turkey | Details | ||
GSK Investigational Site | Ankara | 6560 | Turkey | Details | ||
GSK Investigational Site | Izmir | 35100 | Turkey | Details | ||
GSK Investigational Site | Izmir | 35330 | Turkey | Details | ||
GSK Investigational Site | Kocaeli | 41400 | Turkey | Details | ||
GSK Investigational Site | Mersin | 33343 | Turkey | Details | ||
GSK Investigational Site | Samsun | 55139 | Turkey | Details | ||
GSK Investigational Site | London | W12 0HS | United Kingdom | Details | ||
GSK Investigational Site | Plymouth | PL6 8D8 | United Kingdom | Details | ||
GSK Investigational Site | Southampton | SO16 6YD | United Kingdom | Details | ||
GSK Investigational Site | Stoke on Trent | ST4 6QG | United Kingdom | Details | ||
GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |
CKB CORE allows for only a limited number of monthly page views for un-registered users. However, registration is free and allows for unlimited browsing of the CKB CORE content.
You have reached the monthly page view limit. For continued free access to CKB CORE, please register below: